NCCM
MGNX icon

Nine Chapters Capital Management’s MacroGenics MGNX Stock Holding History

Nine Chapters Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19,700
Closed -$422K – 329
2015
Q3 		$422K Buy
+19,700
New +$618K 0.04% 620
2014
Q3 		– Sell
-12,200
Closed -$265K – 1100
2014
Q2 		$265K Buy
+12,200
New +$256K 0.02% 753

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Nine Chapters Capital Management's MGNX Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 19,700 shares — an estimated $422K sold.

Nine Chapters Capital Management first reported a position in MGNX in Q2 2014 and held it in 2 quarters. The position peaked at $422K in Q3 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 19,700 MacroGenics shares in Q4 2015, an estimated $422K.
  • Nine Chapters Capital Management first reported a position in MacroGenics in Q2 2014 and held it in 2 quarters.
  • Nine Chapters Capital Management's MacroGenics position peaked at $422K in Q3 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.